Chief Development Officer of Trillium Therapeutics Inc. (NASDAQ:TRIL), Petrova Penka, sells 2,708 shares worth $39,843

According to Trillium Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:19 PM, company Chief Development Officer, Petrova Penka disclosed selling 2,708 shares at a cost of $14.71. At the time of this transaction (Jan 07), this trade was worth $39,843 in total. As of Jan 07, Petrova Penka now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Trillium Therapeutics Inc. (NASDAQ:TRIL) Chief Development Officer, Petrova Penka, we have the following information:

    Posted by on Monday January 11 2021, 8:57 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in